ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
批准号:
6752053
负责人:
MARIANNE MANCHESTER
金额:
$31.06万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2006-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract): Despite an effective
vaccine, measles virus (MV) is still the seventh leading cause of death
worldwide. MV causes significant morbidity an mortality due to virus-associated
immunosuppression and kills over 1 million children per year. Why is measles
still a public health problem when a vaccine is available? The extremely
infectious nature of the virus interference with MV vaccination by
maternally-acquired antibodies, and waning immunity in vaccines all contribute
to the stubborn resistance of MV to eradication. The interaction between
viruses and cell-surface receptors is a major determinant of virus tropism an
pathogenesis. For MV, the cell-surface receptor has been identified as the
complement receptor CD46. The normal function of CD46 is to bind complement
components on the cell surface and prevent their deposition on host cells.
Previous studies have shown that complement C3b, the primary ligand for CD46
interacts with regions of the extracellular domain of CD46 near the membrane.
Laboratory strains of MV, in contrast, interact with the N-terminal third of
the extracellular domain of CD46. This interaction not only results in MV
attachment and entry, but can also signal target lymphocytes to downregulate
cytokine production. The long range goal of this project, is to determine how
wild-type MV interacts with the MV receptor CD46 to result in host-cell
attachment, entry and modulation on intracellular signaling. First, emphasis is
placed on mapping the specific interaction between wild-type strains of MV and
the extracellular domain of the CD46 receptor. A combined molecular genetic and
structural analysis will be used to identify and characterize the domain of the
CD46 receptor that are responsible for interacting with wild-type MV to achieve
virus binding, entry an immunosuppressive effects in target host cells. A
second emphasis of this grant is to characterize the signaling events that
occur upon liganding of CD46 by wild-type and laboratory strains of MV and how
these events regulate virus entry and immune function. Determining how the
interaction between MV and CD46 influences intracellular signals is important
not only for understanding how measles-induced immunosuppression occurs, but
provides a potential tool for studying how virus-receptor interactions can
modulate host cell functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multivalent VAccines for Biodefense
-
批准号:7849969
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent VAccines for Biodefense
-
批准号:7739980
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7363773
-
项目类别:
-
资助金额:$49.65万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:8206699
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7545937
-
项目类别:
-
资助金额:$47.37万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7751278
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:8018959
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
COLUMN FRACTION SCREENING OF CPMV PARTICLES
-
批准号:7602763
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2007
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7003678
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7558948
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7360311
-
项目类别:
-
资助金额:$74.67万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:8053071
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7193491
-
项目类别:
-
资助金额:$72.65万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:6860578
-
项目类别:
-
资助金额:$72.28万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6674214
-
项目类别:
-
资助金额:$103.36万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:7188076
-
项目类别:
-
资助金额:$206.49万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6804942
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6852693
-
项目类别:
-
资助金额:$206.03万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:7019138
-
项目类别:
-
资助金额:$206.87万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
-
批准号:6374360
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2000
-
负责人:MARIANNE MANCHESTER
-
依托单位:
海外基金